Huntington’s treatment helps Teva beat profit estimates as CEO eyes newer drug opportunities
By Steven Scheer JERUSALEM (Reuters) -Teva Pharmaceutical Industries on Wednesday reported higher-than-expected second-quarter profit, boosted by a sharp gain in…
